Navigating Regulatory Challenges in the Bovine Colostrum Market The market for bovine colostrum is witnessing a significant surge, driven by growing consumer awareness of its health benefits and recent FDA approval as Generally Recognized as Safe (GRAS). Companies like PanTheryx in the U.S. are capitalizing on this trend, leading to projections of reaching approximately US$ 4.3 billion in revenue by 2027. This article explores the key factors behind the...
0 Shares
24 Views
0 Reviews